The Pharmacology of Longevity: Peptide Edition (Part 1) BPC 157: Experimental Peptide Creates Risk for Athletes FDA moves toward easing restrictions on certain peptides BioPharma Dive Compounded "semaglutide" is not FDA approved semaglutide.com The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York